GLIMEPIRIDE
Product:
Gluconormet
Description:
Gluconormet is an oral antidiabetic agent (glimepiride & metformin HCl) used in the management of type 2 diabetes.
Glimepiride:
Glimepiride (sulphonylurea class), mechanism of action appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells.
Metformin HCl:
Metformin improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose.
Product:
Poze G
Description:
Poze G tablets contain two oral antihyperglycemic agents used in the management of type 2 diabetes: pioglitazone hydrochloride and glimepiride.
Pioglitazone hydrochloride acts primarily by decreasing insulin resistance. It improves sensitivity to insulin in muscle and adipose tissue and inhibits hepatic gluconeogenesis. It reduces circulating insulin levels and improves glycemic control.
Glimepiride is an oral glucose-lowering drug of the sulphonylurea class, which acts by increasing the release of insulin from the pancreatic beta cells.
Product:
Gluconorm
Description:
Gluconorm (glimepiride) is an oral blood-glucose-lowering drug of the sulfonylurea class.